The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma.

MLA

Zhang, Zhiwei, et al. “The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma.” Journal of Clinical Medicine, vol. 12, no. 4, Feb. 2023, p. 1398. EBSCOhost, https://doi.org/10.3390/jcm12041398.

APA

Zhang, Z., Xiong, Q., Xu, Y., Cai, X., Zhang, L., & Zhu, Q. (2023). The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma. Journal of Clinical Medicine, 12(4), 1398. https://doi.org/10.3390/jcm12041398

Chicago

Zhang, Zhiwei, Qunli Xiong, Yongfeng Xu, Xuebin Cai, Lisha Zhang, and Qing Zhu. 2023. “The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma.” Journal of Clinical Medicine 12 (4): 1398. doi:10.3390/jcm12041398.